novo nordisk semaglutide mash ESSENCE GLP-1 therapies: a new frontier
Description
A UConn Health researcher explains how her lab is focusing on how GLP-1 medications affect the brain and how they can be improved for the future
GLP-1 Semaglutide + Cagrilintide studied in appetite and metabolic pathway research models.
A new wave of weight loss medications like Ozempic is changing the game for people struggling with obesity
A subcutaneous injection (SQ or Sub-Q injection) is a shot administered just under the surface of the skin
Semaglutide for weight loss is administered as a once-weekly injection, starting at a low dose and increasing gradually over 16+ weeks
